Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non-small-cell lung cancer patients: The Spanish Lung Cancer Group trial 9901

Journal of Clinical Oncology

Volumn 25, Issue 30, 2007, Pages 4736-4742

  Garrido, Pilar ^a   González Larriba, José Luis ^a   Insa, Amelia ^a   Provencio, Mariano ^a   Torres, Antonio ^a   Isla, Dolores ^a   Sanchez, José Miguel ^a   Cardenal, Felipe ^a   Domine, Manuel ^a   Barcelo, Jose Ramon ^a   Tarrazona, Vicente ^a   Varela, Andres ^a   Aguilo, Rafael ^a   Astudillo, Julio ^a   Muguruza, Ignacio ^a   Artal, Angel ^a   Hernando Trancho, Florentino ^a   Massuti, Bartomeu ^a   Sanchez Ronco, Maria ^a   Rosell, Rafael ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; GEMCITABINE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; TAXOID;

ADULT; AGED; ANEMIA; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LIVER TOXICITY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; NAUSEA; NEUTROPENIA; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SENSORY NEUROPATHY; SPAIN; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SURVIVAL TIME; THORACOTOMY; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING; ADENOCARCINOMA; CLINICAL TRIAL; LARGE CELL CARCINOMA; LUNG TUMOR; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; REMISSION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; REMISSION INDUCTION; SURVIVAL RATE; TAXOIDS;

EID: 36048941381     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.12.0014     Document Type: Article

References (27)

1. Skarin A, Jochelson M, Sheldon T, et al: Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: Long-term follow-up in 41 patients. J Surg Oncol 40:266-274, 1989
2. Pass HI, Pogrebniak HW, Steinberg SM, et al: Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis. Ann Thorac Surg 53:992-998, 1992
3. Roth JA, Fossella F, Komaki R, et al: A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 86:673-680, 1994
4. Rosell R, Gomez-Codina J, Camps C, et al: A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330:153-158, 1994
5. Sridhar KS, Thurer R, Kim Y, et al: Multimodality treatment of non-small cell lung cancer: Response to cisplatin, VP-16, and 5-FU chemotherapy and to surgery and radiation therapy. J Surg Oncol 38:193-215, 1988
6. Rusch VW, Albain KS, Crowley JJ, et al: Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy: A Southwest Oncology Group trial. J Thorac Cardiovasc Surg 105:97-104, 1993
7. Stamatis G, Eberhardt W, Stuben G, et al: Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: Long-term results. Ann Thorac Surg 68:1144-1149, 1999
8. Rosell R, Lopez-Cabrerizo MP, Astudillo J: Preoperative chemotherapy for stage IIIA non-small cell lung cancer. Curr Opin Oncol 9:149-155, 1997
9. Martini N, Kris MG, Flehinger BJ, et al: Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients. Ann Thorac Surg 55:1365-1373, 1993
10. Lorent N, De Leyn P, Lievens Y, et al: Longterm survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: Analysis of a 7-year prospective experience. Ann Oncol 15:1645-1653, 2004
11. Sugarbaker DJ, Herndon J, Kohman LJ, et al: Results of Cancer and Leukemia Group B Protocol 8935: A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer - Cancer and Leukemia Group B Thoracic Surgery Group. J Thorac Cardiovasc Surg 109:473-483, 1995
12. Van Meerbeeck JP, Kramer GWPM, Van Schil PEY, et al: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 99:442-450, 2007
13. Albain KS, Rusch VW, Crowley JJ, et al: Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13:1880-1892, 1995
14. Felip E, Rosell R, Alberola V, et al: Preoperative high-dose cisplatin versus moderate-dose cisplatin combined with ifosfamide and mitomycin in stage IIIA (N2) non small-cell lung cancer: Results of a randomized multicenter trial. Clin Lung Cancer 1:287-293, 2000
15. Albain KS, Crowley JJ, Turrisi AT 3rd, et al: Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: A Southwest Oncology Group phase II study, SWOG 9019. J Clin Oncol 20:3454-3460, 2002
16. Martin J, Ginsberg RJ, Venkatraman ES, et al: Long-term results of combined-modality therapy in resectable non-small-cell lung cancer. J Clin Oncol 20:1989-1995, 2002
17. Grunenwald DH, Andre F, Le Pechoux C, et al: Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer. J Thorac Cardiovasc Surg 122:796-802, 2001
18. Eberhardt W, Wilke H, Stamatis G, et al: Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: Mature results of a phase II trial. J Clin Oncol 16:622-634, 1998
19. Ichinose Y, Fukuyama Y, Asoh H, et al: Induction chemoradiotherapy and surgical resection for selected stage IIIB non-small-cell lung cancer. Ann Thorac Surg 76:1810-1814, 2003
20. Betticher DC, Hsu Schmitz SF, Totsch M, et al: Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study. Br J Cancer 94:1099-1106, 2006
21. Hoekstra CJ, Stroobants SG, Smit EF, et al: Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer. J Clin Oncol 23:8362-8370, 2005
22. Eschmann SM, Friedel G, Paulsen F, et al: Repeat (18)F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer. Lung Cancer 55:165-171, 2007
23. Choi NC, Carey RW, Daly W, et al: Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J Clin Oncol 15:712-722, 1997
24. Betticher DC, Hsu Schmitz SF, Totsch M, et al: Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: A multicenter phase II trial. J Clin Oncol 21:1752-1759, 2003
25. Albain KS, Swann RS, Rusch V, et al: Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA (pN2) non-small-cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309). J Clin Oncol 23:624s, 2005 (suppl; abstr 7014)
26. Biesma B, Manegold C, Smit HJ, et al: Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: A phase II study of the European Organization for Research and Treatment of Cancer (EORTC 08984). Eur J Cancer 42:1399-1406, 2006
27. Cappuzzo F, De Marinis F, Nelli F, et al: Phase II study of gemcitabine-cisplatin-paclitaxel triplet as induction chemotherapy in inoperable, locally-advanced non-small cell lung cancer. Lung Cancer 42:355-361, 2003